1-2 of 2
Bernt J. von Scholten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

Daniel G.K. Rasmussen, Tine W. Hansen, Bernt J. von Scholten, Signe H. Nielsen, Henrik Reinhard, Hans-Henrik Parving, Martin Tepel, Morten A. Karsdal, Peter K. Jacobsen, Federica Genovese, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2018;41(7):1493–1500
https://doi.org/10.2337/dc17-2392
Published: 11 April 2018
View article titled, Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria
Open the PDF for Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria in another window
Includes: Supplementary data
Journal Articles

No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial

Laszlo Hegedüs, Steven I. Sherman, R. Michael Tuttle, Bernt J. von Scholten, Søren Rasmussen, Julie D. Karsbøl, Gilbert H. Daniels, for the LEADER Publication Committee on behalf of the LEADER Trial Investigators
Journal: Diabetes Care
Diabetes Care 2018;41(3):620–622
https://doi.org/10.2337/dc17-1956
Published: 26 December 2017
View article titled, No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial
Open the PDF for No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial in another window
Includes: Supplementary data